PETS
PetMed Express, Inc.NASDAQHealthcare$2.29+2.62%ClosedMarket Cap: $49.0M
As of 2026-04-06
Valuation
P/E (TTM)
—
PEG
—
P/B
1.51
P/S
0.28
EV/EBITDA
-0.50
DCF Value
$8.94
FCF Yield
-45.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
29.0%
Operating Margin
-17.4%
Net Margin
-35.5%
ROE
-122.1%
ROA
-73.7%
ROIC
-94.2%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q3 2026 | $40.7M | 23.3% | $-10.5M | $-10.6M | $-0.50 | — |
| Q2 2026 | $44.4M | 28.0% | $-8.4M | $-8.5M | $-0.41 | — |
| Q1 2026 | $51.2M | 23.7% | $-6.9M | $-34.2M | $-1.65 | — |
| Q4 2025 | $46.5M | 40.8% | $-6.0M | $-11.6M | $-0.56 | — |
| FY 2025 | $227.0M | 30.5% | $-1.5M | $-6.3M | $-0.30 | — |
| Q3 2025 | $53.0M | 28.1% | $-450.0K | $-707.0K | $-0.03 | — |
| Q2 2025 | $59.6M | 29.1% | $554.0K | $2.3M | $0.11 | — |
| Q1 2025 | $68.0M | 23.9% | $4.4M | $3.8M | $0.18 | — |
| Q4 2024 | $66.5M | 24.5% | $-3.9M | $-5.0M | $-0.25 | — |
| FY 2024 | $274.1M | 28.4% | $-7.0M | $-7.5M | $-0.37 | $0.60 |
| Q3 2024 | $65.3M | 27.4% | $-3.1M | $-2.0M | $-0.10 | — |
| Q2 2024 | $71.0M | 25.8% | $875.0K | $715.0K | $0.03 | $0.30 |